83.70
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Incyte Corp Borsa (INCY) Ultime notizie
What candlestick patterns are forming on Incyte Corporation2025 Risk Factors & Reliable Breakout Forecasts - Newser
Should you wait for a breakout in Incyte CorporationEarnings Miss & Smart Allocation Stock Reports - Newser
What indicators show strength in Incyte CorporationPortfolio Risk Summary & Fast Moving Trade Plans - Newser
Published on: 2025-08-28 10:23:57 - Newser
Will breakout in Incyte Corporation lead to full recoveryDollar Strength & Capital Efficiency Focused Ideas - Newser
Applying Elliott Wave Theory to Incyte CorporationJuly 2025 Movers & Reliable Volume Spike Alerts - Newser
What’s the recovery path for long term holders of Incyte CorporationJuly 2025 Decliners & Breakout Confirmation Alerts - Newser
Long term hold vs stop loss in Incyte CorporationWeekly Trade Report & Safe Capital Growth Plans - Newser
Incyte Corporation (INCY) Expands Precision Medicine with QIAGEN Partnership - Insider Monkey
Can technical indicators confirm Incyte Corporation’s reversalJuly 2025 Trends & Target Return Focused Stock Picks - Newser
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 27, 2025 - BioSpace
Quantitative breakdown of Incyte Corporation recent moveWeekly Stock Recap & Safe Investment Capital Preservation Plans - Newser
Chart based analysis of Incyte Corporation trends2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser
Incyte reports inducement grant under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
How sentiment analysis helps forecast Incyte CorporationMarket Sentiment Summary & Long-Term Safe Investment Ideas - Newser
Using RSI to spot recovery in Incyte CorporationMarket Trend Summary & Growth Focused Entry Reports - Newser
Will Incyte Corporation stock recover after recent dropQuarterly Investment Review & Safe Entry Momentum Tips - Newser
What institutional flow reveals about Incyte CorporationBull Run & Safe Capital Growth Plans - Newser
What Fibonacci levels say about Incyte Corporation reboundLayoff News & Safe Entry Zone Tips - Newser
Three Biotech Companies to Watch: Boston Scientific, Arcutis Biotherapeutics, and Incyte Corporation - AInvest
How institutional ownership impacts Incyte Corporation stockJuly 2025 Highlights & Safe Swing Trade Setup Alerts - Newser
Will Incyte Corporation rebound enough to break evenJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
How to escape a deep drawdown in Incyte Corporation2025 Growth vs Value & Weekly Market Pulse Updates - Newser
Incyte appoints Soni Basi as new chief human resources officer - Investing.com
Incyte Announces Executive Changes, Effective August 25, 2025 - MarketScreener
Incyte Corporation Company’s Quarterly Earnings Growth: What the Numbers SayQuarterly Profit Summary & Risk Controlled Daily Plans - Newser
Analyzing Incyte Corporation with risk reward ratio charts2025 Investor Takeaways & Real-Time Chart Breakout Alerts - Newser
How Incyte Corporation stock performs during market volatility2025 Major Catalysts & AI Optimized Trade Strategies - beatles.ru
Market Wrap: Is Incyte Corporation impacted by rising rates2025 Market Sentiment & Weekly High Momentum Picks - theviewers.co.kr
Apache, Incyte, Prudential, ON Semiconductor: 'Mad Money' Lightning Round - TheStreet
Incyte Corp. Stock Down Despite Market Surge - AInvest
JP Morgan Maintains Incyte (INCY) Rating, Raises Price Target to $73 | INCY Stock News - GuruFocus
Eli Lilly (LLY) Shares Lower After Update on Rheumatoid Arthritis Drug - TheStreet
JPMorgan Adjusts Price Target on Incyte to $73 From $67, Maintains Neutral Rating - MarketScreener
Incyte describes new MRGPRX2 antagonists - BioWorld MedTech
Are Wall Street Analysts Predicting Incyte Stock Will Climb or Sink? - MSN
INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold? - Yahoo Finance
Are Wall Street Analysts Predicting Incyte Stock Will Climb Or Sink? - Barchart.com
Using flow based indicators on Incyte CorporationQuarterly Earnings Summary & Free Weekly Watchlist of Top Performers - Newser
Incyte to Present at Upcoming Investor Conferences - MarketScreener
Incyte Corp. stock underperforms Monday when compared to competitors - MarketWatch
Will Incyte Corporation Reverse From Oversold ConditionsJuly 2025 Intraday Action & Daily Risk Controlled Trade Plans - metrotimes.co.kr
Immuno-Oncology Stocks Q2 In Review: Incyte (NASDAQ:INCY) Vs Peers - Yahoo Finance
Incyte rises on results beat, lifted Jakafi guidance - MSN
Using portfolio simulators with Incyte Corporation included2025 Top Decliners & Risk Controlled Daily Plans - Newser
Incyte Corp (INCY) Set to Outperform Market: Strong Financial Growth and Competitive Advantage - AInvest
Cancer Stock Soars While This China Tech Stock Heads To New Highs - Investor's Business Daily
Incyte CFO Christiana Stamoulis to Step Down in September - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):